HAMILTON, ON, June 1, 2023 /PRNewswire/ – AtomVie Global Radiopharma Inc. (AtomVie), a global-leading CDMO for the GMP manufacturing and worldwide distribution of radiopharmaceuticals, today announced the closing of its Tranche 2 Series A financing led by its current investor, Avego Management, LLC (“Avego”). Along with Tranche 1 closed in August 2022, AtomVie has now raised … Read more
PHILADELPHIA, June 1, 2023 /PRNewswire/ — Kang Haggerty LLC announced today that they obtained a $9 Million settlement in a non-intervened fentanyl false claims act qui tam case against private equity firm Belhealth Investment Partners, its principals, Harold Blue, Inder Tallur, and Dennis Drislane, and its pharmacy portfolio companies, Linden Care and Quick Care. The … Read more
DUBLIN, June 1, 2023 /PRNewswire/ — The “Global Tuberculosis Treatment Market Report and Forecast 2023-2031” report has been added to ResearchAndMarkets.com’s offering. The global tuberculosis (TB) treatment market size was valued at USD 1.8 billion in 2022 and is projected to grow at a CAGR of 7.57% during the forecast period of 2023-2031 to reach a … Read more
LINKÖPING, Sweden, June 1, 2023 /PRNewswire/ — International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a contract with two Belgian hospitals to provide them with its enterprise imaging solution as a cloud service, Sectra One Cloud. This will enable the hospitals, AZ Sint Jan and AZ Sint Lucas, to share … Read more
LUND, Sweden, June 1, 2023 /PRNewswire/ — Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced that it has attained reimbursement in Belgium for its first-in-class treatment, Idefirix, for the desensitization treatment of highly sensitized adult patients prior to kidney transplant from a deceased donor. Idefirix is available … Read more
BRII-297, a first-of-its-kind treatment option for anxiety and depressive disorders, has the potential to enable greater therapeutic adherence and convenience for patients DURHAM, N.C. and BEIJING, May 31, 2023 /PRNewswire/ — Brii Biosciences Limited (“Brii Bio” or the “Company”, stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with … Read more
DUBLIN, May 31, 2023 /PRNewswire/ — The “Global Analgesics Market: Analysis By Drug Class (Opioids and Non-Opioids), By Route of Administration (Oral, Topical, Intravenous, Transdermal and Rectal), By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2028” report has been added to ResearchAndMarkets.com’s offering. The global analgesics market value is projected … Read more
DUBLIN, May 31, 2023 /PRNewswire/ — The “Global HIV Treatment Market: Analysis By Product, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2030” report has been added to ResearchAndMarkets.com’s offering. The global HIV treatment market in 2022 stood at US$22.38 billion, and is likely to reach US$25.49 billion by 2030. … Read more
STOCKHOLM, May 31, 2023 /PRNewswire/ — Redwood Pharma AB (publ) announces positive results from the company’s clinical study with RP501, a medical technology self-care product being developed for the treatment of dry eye. The results show that RP501 is safe and well-tolerated and that the product produces statistically significant positive results on several subjective efficacy measures, … Read more
NEW YORK, May 31, 2023 /PRNewswire/ — The global medical waste disposal market size is estimated to grow by USD 3,323.84 million from 2022 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 5.5% , however, the growth momentum will progress during the forecast period. North America is estimated to account for 36% of the global … Read more